National Institute on Drug Abuse: Combination Treatment for Methamphetamine Use Disorder Shows Promise in NIH Study
January 14, 2021
January 14, 2021
BETHESDA, Maryland, Jan. 14 (TNSJou) -- The U.S. Department of Health and Human Services' National Institute on Drug Abuse issued the following news release on Jan. 13:
A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to c . . .
A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to c . . .